Bertolini Jeffrey sold $3K of CARL
Bertolini Jeffrey (Chief Operating Officer) sold 243 shares of CARLSMED, INC. (CARL) at $13.99 on 2026-09-30 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale is routine and unlikely to move the stock materially.
Market read
A small insider sale with limited market impact; traders may note the transaction but no immediate action is warranted.
What to watch
Potential upcoming corporate actions or financing needs not disclosed in the filing.
Background
Form 4 filings disclose insider transactions and are primary sources for such events.
Ticker impact
COO Bertolini Jeffrey sold 243 shares for $13.99 each via a 10b5-1 plan, reducing his stake to 22,489 shares.
potential modest downward pressure as the market prices the insider sell.
The transaction size is small relative to float and disclosed via a Form 4, typical of routine liquidity events.
Market effects
None significant; the sale does not affect the broader healthcare sector.
No regional impact; the filing is company‑specific.
Minimal global relevance.
Counterpoint
The sale could be interpreted as a lack of confidence, but the size is too small to signal material concerns.
Key entities
- personBertolini Jeffrey
Chief Operating Officer of Carlsmed, Inc.